-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Jiankang Yuan's large-specification budesonide suspension is approved, and the initial inhaled product matrix is formed.
Published Time:
2020-12-11
Cailian Press (Shenzhen, reporter Ding Rong) news, Healthy Yuan (600380.SH) The much-anticipated inhaled budesonide suspension has made new progress. On the evening of December 10, Healthy Yuan issued an announcement that the company recently received the "Drug Registration Certificate" issued and approved by the National Medical Products Administration. The common name of the drug is inhaled budesonide suspension. A relevant person in charge of Healthy Yuan said in an interview with Cailian Press reporters on the morning of December 11 that the company has successively obtained approvals for several inhaled preparations, which is in line with the rhythm of previous deployments. This large-specification budesonide suspension is a core product with a large market volume.
The relevant person in charge of the company also pointed out: "In July this year, the company obtained the drug registration certificate for the 2ml:0.5mg small-specification inhaled budesonide suspension, and now the 2ml:1mg large-specification has also obtained the drug registration certificate. The inhaled preparation product matrix is progressing smoothly and is in line with expectations. In the next stage, the company will accelerate the development of new products into hospitals to promote the company's performance growth."
According to the announcement, the product is independently developed by the company with a specification of 2ml:1mg. It is mainly used to treat bronchial asthma and can replace or reduce oral steroids. Budesonide is a glucocorticoid that treats asthma through local anti-inflammatory effects. Inhaled therapy is the preferred therapy for preventing and treating asthma and other respiratory diseases. Inhaled drugs can directly reach the respiratory tract and lungs, so they have the advantages of rapid onset, small dosage, and small side effects. Up to now, the company has accumulated direct research and development costs of approximately RMB 30.6728 million for this inhaled budesonide suspension.
Budesonide inhalation suspension was first developed and produced by AstraZeneca Company, first launched in the UK in 1991, and entered the Chinese market in 2001, with specifications of 2ml:1mg and 2ml:0.5mg. According to IQVIA Sampling statistics estimated data, the domestic terminal sales of budesonide inhalation suspension in 2019 was approximately RMB 5.632 billion. According to the website of the Center for Drug Evaluation of the National Medical Products Administration and the Xian Da database, as of now, there are two domestic manufacturers, Zhengda Tianqing and Healthy Yuan, that have been approved to market this drug, and three other domestic manufacturers have applied for it.
Last year, Healthy Yuan's approved inhaled preparations included levalbuterol and compound ipratropium bromide, two varieties. This year, it approved single ipratropium bromide and budesonide suspension, two varieties.
It is understood that inhaled administration has a rapid onset and fewer side effects, and China's respiratory inhalation preparation market is rapidly rising. However, due to the high R&D barriers of respiratory inhalation preparations, the vast majority of the Chinese market share is occupied by foreign pharmaceutical companies. Healthy Yuan is one of the few domestic companies that include inhaled preparations as its core business.
Transferred from: "Cailian Press"
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home